Fatal anaphylaxis with neuromuscular blocking agents: A risk factor and management analysis

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 69, Issue 7, 2014, Pages 954-959

  Reitter, M ^a   Petitpain, N ^a   Latarche, C ^a   Cottin, J ^b   Massy, N ^c   Demoly, P ^d   Gillet, P ^a   Mertes, P M ^e  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c ROUEN UNIVERSITY HOSPITAL   (France)

^d MONTPELLIER UNIVERSITY HOSPITAL   (France)

^e HÔPITAL CIVIL   (France)

Author keywords

anaphylaxis; anesthesia; epinephrine; mortality; neuromuscular blocking agents

Indexed keywords

ADRENALIN; ATRACURIUM BESILATE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CISATRACURIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MIVACURIUM; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; ROCURONIUM; SUXAMETHONIUM; VECURONIUM;

ADULT; ANAPHYLAXIS; ARTICLE; BRONCHOSPASM; CARDIOPULMONARY INSUFFICIENCY; CARDIOVASCULAR DISEASE; COLLAPSE; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; FETUS DISEASE; FRANCE; HUMAN; HYPERTENSION; HYPOTENSION; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBESITY; ORTHOPEDIC SURGERY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; TREATMENT OUTCOME; AGED; CHEMICALLY INDUCED; COMORBIDITY; DRUG SURVEILLANCE PROGRAM; MIDDLE AGED;

ADULT; AGED; ANAPHYLAXIS; COMORBIDITY; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR BLOCKING AGENTS; OBESITY; PHARMACOVIGILANCE; RISK FACTORS;

EID: 84902001377     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12426     Document Type: Article

References (27)

1. Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, et al. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001; 56: 813-824. (Pubitemid 32800388)
2. Mertes PM, Alla F, Trechot P, Auroy Y, Jougla E, Groupe d'Etudes des Réactions Anaphylactoïdes Peranesthésiques. Anaphylaxis during anesthesia in France: an 8-year national survey. J Allergy Clin Immunol 2011; 128: 366-373.
3. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, et al. Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006; 117: 391-397. (Pubitemid 43190153)
4. Simons FE, Ardusso LR, Bilo MB, Dimov V, Ebisawa M, El-Gamal YM, et al. 2012 update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol 2012; 12: 389-399.
5. Mertes PM, Malinovsky JM, Jouffroy L, Working Group of the SFAR and SFA, Aberer W, Terreehorst I, et al. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. J Investig Allergol Clin Immunol 2011; 21: 442-453.
6. Soar J, Pumphrey R, Cant A, Clarke S, Corbett A, Dawson P, et al. Emergency treatment of anaphylactic reactions-guidelines for healthcare providers. Resuscitation 2008; 77: 157-169.
7. Kroigaard M, Garvey LH, Gillberg L, Johansson SG, Mosbech H, Florvaag E, et al. Scandinavian Clinical Practice Guidelines on the diagnosis, management and follow-up of anaphylaxis during anaesthesia. Acta Anaesthesiol Scand 2007; 51: 655-670. (Pubitemid 46918542)
8. Pumphrey RS,. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000; 30: 1144-1150. (Pubitemid 30619768)
9. Moore N, Biour M, Paux G, Loupi E, Begaud B, Boismare F, et al. Adverse drug reaction monitoring: doing it the French way. Lancet 1985; 2: 1056-1058. (Pubitemid 16206749)
10. Ring J, Laubenthal H, Messmer K,. Incidence and classification of adverse reactions to plasma substitutes. Klin Wochenschr 1982; 60: 997-1002. (Pubitemid 12050167)
11. Mitsuhata H, Hasegawa J, Matsumoto S, Ogawa R,. [The epidemiology and clinical features of anaphylactic and anaphylactoid reactions in the perioperative period in Japan: a survey with a questionnaire of 529 hospitals approved by Japan Society of Anesthesiology]. Masui 1992; 41: 1825-1831. (Pubitemid 23010765)
12. Hepner DL, Castells MC,. Anaphylaxis during the perioperative period. Anesth Analg 2003; 97: 1381-1395. (Pubitemid 37310138)
13. Light KP, Lovell AT, Butt H, Fauvel NJ, Holdcroft A,. Adverse effects of neuromuscular blocking agents based on yellow card reporting in the U.K.: are there differences between males and females? Pharmacoepidemiol Drug Saf 2006; 15: 151-160.
14. Gibbs NM, Sadleir PH, Clarke RC, Platt PR,. Survival from perioperative anaphylaxis in Western Australia 2000-2009. Br J Anaesth 2013; 111: 589-593.
15. Mertes PM, Laxenaire MC, Alla F, Groupe d'Etudes des Réactions Anaphylactoïdes Peranesthésiques. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003; 99: 536-545. (Pubitemid 37051967)
16. Fisher MM, Baldo BA,. The incidence and clinical features of anaphylactic reactions during anesthesia in Australia. Ann Fr Anesth Reanim 1993; 12: 97-104. (Pubitemid 23176406)
17. Gray LD, Morris CG,. Organisation and planning of anaesthesia for emergency surgery. Anaesthesia 2013; 68 (Suppl 1): 3-13.
18. Perry JJ, Lee JS, Sillberg VA, Wells GA,. Rocuronium versus succinylcholine for rapid sequence induction intubation. Cochrane Database Syst Rev 2008: CD002788.
19. Mertes PM, Laxenaire MC,. Allergic reactions occurring during anaesthesia. Eur J Anaesthesiol 2002; 19: 240-262. (Pubitemid 34984199)
20. Dong SW, Mertes PM, Petitpain N, Hasdenteufel F, Malinovsky JM, GERAP. Hypersensitivity reactions during anesthesia. Results from the ninth French survey (2005-2007). Minerva Anestesiol 2012; 78: 868-878.
21. Fisher MM, Doig GS,. Prevention of anaphylactic reactions to anaesthetic drugs. Drug Saf 2004; 27: 393-410. (Pubitemid 38608458)
22. Sadleir PH, Clarke RC, Bunning DL, Platt PR,. Anaphylaxis to neuromuscular blocking drugs: incidence and cross-reactivity in Western Australia from 2002 to 2011. Br J Anesthesia 2013; 110: 981-987.
23. Garvey LH, Belhage B, Kroigaard M, Husum B, Malling HJ, Mosbech H,. Treatment with epinephrine (adrenaline) in suspected anaphylaxis during anesthesia in Denmark. Anesthesiology 2011; 115: 111-116.
24. Ford SA, Kam PC, Baldo BA, Fisher MM,. Anaphylactic or anaphylactoid reactions in patients undergoing cardiac surgery. J Cardiothorac Vasc Anesth 2001; 15: 684-688. (Pubitemid 34016101)
25. Lafforgue E, Sleth JC, Pluskwa F, Saizy C,. [Successful extracorporeal resuscitation of a probable perioperative anaphylactic shock due to atracurium]. Ann Fr Anesth Reanim 2005; 24: 551-555. (Pubitemid 40724761)
26. Longrois D, Lejus C, Constant I, Bruyere M, Mertes PM,. [Treatment of hypersensitivity reactions and anaphylactic shock occurring during anaesthesia]. Ann Fr Anesth Reanim 2011; 30: 312-322.
27. Mertes PM, Demoly P, Malinovsky JM,. Hypersensitivity reactions in the anesthesia setting/allergic reactions to anesthetics. Curr Opin Allergy Clin Immunol 2012; 12: 361-368.